These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35151938)

  • 1. Methoxpropamine (MXPr) in powder, urine and hair samples: Analytical characterization and metabolite identification of a new threat.
    Goncalves R; Castaing N; Richeval C; Ducint D; Titier K; Morvan E; Grélard A; Loquet A; Molimard M
    Forensic Sci Int; 2022 Apr; 333():111215. PubMed ID: 35151938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic study of new psychoactive substance methoxpropamine in mice by UHPLC-QTOF-HRMS.
    Massano M; Gerace E; Borsari M; Marti M; Tirri M; Ververi C; Alladio E; Vincenti M; Salomone A
    Drug Test Anal; 2023 May; 15(5):586-594. PubMed ID: 36710266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of deschloro-N-ethyl-ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high-resolution accurate mass spectrometry.
    Larabi IA; Zerizer F; Ameline A; Etting I; Joseph D; Kintz P; Alvarez JC
    Drug Test Anal; 2021 Jun; 13(6):1108-1117. PubMed ID: 33538127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method development for the identification of methoxpropamine, 2-fluoro-deschloroketamine and deschloroketamine and their main metabolites in blood and hair and forensic application.
    Mestria S; Odoardi S; Biosa G; Valentini V; Di Masi G; Cittadini F; Strano-Rossi S
    Forensic Sci Int; 2021 May; 323():110817. PubMed ID: 33971504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
    Grafinger KE; Hädener M; König S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE).
    Gicquel T; Richeval C; Mesli V; Gish A; Hakim F; Pelletier R; Cornez R; Balgairies A; Allorge D; Gaulier JM
    Forensic Sci Int; 2021 Jul; 324():110852. PubMed ID: 34049075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of extensive 2-fluorodeschloroketamine metabolism in pooled human liver microsomes, urine and hair from an addicted patient using high-resolution accurate mass spectrometry.
    Joseph D; Lesueur C; Zerizer F; Fenot A; Alvarez JC; Larabi IA
    J Anal Toxicol; 2023 Jul; 47(6):504-516. PubMed ID: 37279563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
    Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
    Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700.
    Richeval C; Gaulier JM; Romeuf L; Allorge D; Gaillard Y
    Int J Legal Med; 2019 Jan; 133(1):133-142. PubMed ID: 30443678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
    Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
    Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.
    Richeval C; Gicquel T; Hugbart C; Le Dare B; Allorge D; Morel I; Gaulier JM
    Curr Pharm Biotechnol; 2017; 18(10):806-814. PubMed ID: 29173157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Broecker S; Herre S; Pragst F
    Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination and metabolic profiling of synthetic cathinone eutylone in vitro and in urine samples by liquid chromatography tandem quadrupole time-of-flight mass spectrometry.
    Yeh YL; Wang SM
    Drug Test Anal; 2022 Jul; 14(7):1325-1337. PubMed ID: 35332690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
    Moosmann B; Bisel P; Westphal F; Wilde M; Kempf J; Angerer V; Auwärter V
    Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of new psychoactive substances in hair and urine samples of individuals subject to drug testing in driving license regranting-A toxicological perspective.
    Fels H; Musshoff F; Graw M; DeVol D; Wagner T; Holzer A
    Drug Test Anal; 2023 Aug; 15(8):919-926. PubMed ID: 37332090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
    A Michely JA; Manier SK; Caspar AT; Brandt SD; Wallach J; Maurer HH
    Curr Neuropharmacol; 2017; 15(5):692-712. PubMed ID: 27758707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for synthetic cannabinoids in hair by using LC-QTOF MS: a new and powerful approach to study the penetration of these new psychoactive substances in the population.
    Gottardo R; Sorio D; Musile G; Trapani E; Seri C; Serpelloni G; Tagliaro F
    Med Sci Law; 2014 Jan; 54(1):22-7. PubMed ID: 23842479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.